ClinicalTrials.Veeva

Menu

Cerebral Microembolism in the Critically Ill With Acute Kidney Injury (COMET-AKI)

I

Insel Gruppe AG, University Hospital Bern

Status

Terminated

Conditions

Cerebral Embolism

Treatments

Device: Renal replacement therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT02621749
199/2015

Details and patient eligibility

About

The primary objective of this study is to investigate the impact of continuous renal replacement therapy and intermittent renal replacement therapy on microbubble / cerebral microemboli generation in a cohort of critically ill patients with dialysis-dependent acute kidney injury.

Enrollment

66 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • > 18 yrs.
  • Signed IC

Exclusion criteria

  • Heart disease (PFO, ASD, VSD, severe valvular disease)
  • Atrial fibrillation
  • Cerebrovascular pathology
  • Missing temporal bone window
  • Allergy to plastic contained in the investigative device (transcranial Doppler)
  • Chronic kidney disease
  • Pregnancy
  • Participation in another study

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

66 participants in 2 patient groups

CRRT group
Active Comparator group
Description:
the CRRT group receives continuous renal replacement therapy for acute kidney injury
Treatment:
Device: Renal replacement therapy
IRRT group
Active Comparator group
Description:
the IRRT group receives intermittent renal replacement therapy after termination of CRRT.
Treatment:
Device: Renal replacement therapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems